Our competing grant renewal Drug-free Macromolecular Therapeutics R01 focusing on MATCH for multiple myeloma (Henry and Jane, MPIs) received a 1% ranking in the INN Study Section.
x
Our competing grant renewal Drug-free Macromolecular Therapeutics R01 focusing on MATCH for multiple myeloma (Henry and Jane, MPIs) received a 1% ranking in the INN Study Section.